148 related articles for article (PubMed ID: 21430883)
1. Study of reservoir effect of clobetasol propionate cream in an experimental animal model using histamine-induced wheal suppression test.
Abidi A; Ahmad F; Singh SK; Kumar A
Indian J Dermatol; 2010 Oct; 55(4):329-33. PubMed ID: 21430883
[TBL] [Abstract][Full Text] [Related]
2. Comparison of reservoir effect of topical corticosteroids in an experimental animal model by histamine-induced wheal suppression test.
Abidi A; Ahmad F; Singh SK; Kumar A
Indian J Pharmacol; 2012; 44(6):722-5. PubMed ID: 23248401
[TBL] [Abstract][Full Text] [Related]
3. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
Singh SK; Nasir F
Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
[TBL] [Abstract][Full Text] [Related]
4. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
Singh S; Gupta A; Pandey SS; Singh G
Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of clobetasol propionate with varying dilutions of emollient determined by histamine wheal suppression test.
Barathi M; Rai R; Srinivas CR
Indian J Dermatol; 2011; 56(5):527-8. PubMed ID: 22121270
[TBL] [Abstract][Full Text] [Related]
6. Half an hour versus three hour contact of topical steroid (clobetasol propionate).
Rai R; Uppal M; Sharma NK; Srinivas CR; Mathew A
Indian J Dermatol Venereol Leprol; 2004; 70(4):214-6. PubMed ID: 17642617
[TBL] [Abstract][Full Text] [Related]
7. Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses.
Feldman SR
Curr Ther Res Clin Exp; 2005 May; 66(3):154-71. PubMed ID: 24672120
[TBL] [Abstract][Full Text] [Related]
8. A comparative clinical evaluation of once daily versus alternate day application of topical clobetasol propionate cream in psoriasis.
Abidi A; Ahmad F; Singh SK
J Clin Diagn Res; 2013 Jan; 7(1):100-5. PubMed ID: 23449948
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study.
Sidgiddi S; Naqvi SMH; Shenoy M; Balraj DN; Kothari J; Gupta S; Haq R; Mittal R; Mehta S; Mane A
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1717-1732. PubMed ID: 34453262
[TBL] [Abstract][Full Text] [Related]
10. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression.
Singh G; Singh PK
Int J Dermatol; 1986 Jun; 25(5):324-6. PubMed ID: 3721670
[TBL] [Abstract][Full Text] [Related]
11. Effect of topical corticosteroid application frequency on histamine-induced wheals.
Narasimha SK; Srinivas CR; Mathew AC
Int J Dermatol; 2005 May; 44(5):425-7. PubMed ID: 15869544
[TBL] [Abstract][Full Text] [Related]
12. Treating umbilical granuloma with topical clobetasol propionate cream at home is as effective as treating it with topical silver nitrate in the clinic.
Brødsgaard A; Nielsen T; Mølgaard U; Pryds O; Pedersen P
Acta Paediatr; 2015 Feb; 104(2):174-7. PubMed ID: 25297721
[TBL] [Abstract][Full Text] [Related]
13. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
Uliasz A; Zeichner J; Soung J; Wong V; Lebwohl M
Cutis; 2008 Jun; 81(6):517-9. PubMed ID: 18666395
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.
Angelo JS; Kar BR; Thomas J
Indian J Dermatol Venereol Leprol; 2007; 73(1):65. PubMed ID: 17319037
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Single-Blind Trial of Clobetasol Propionate 0.05% Cream Under Silicone Dressing Occlusion Versus Intra-Lesional Triamcinolone for Treatment of Keloid.
Nor NM; Ismail R; Jamil A; Shah SA; Imran FH
Clin Drug Investig; 2017 Mar; 37(3):295-301. PubMed ID: 27888448
[TBL] [Abstract][Full Text] [Related]
16. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM
J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695
[TBL] [Abstract][Full Text] [Related]
17. Determination of the formation of the stratum corneum reservoir for two different corticosteroid formulations using tape stripping combined with UV/VIS spectroscopy.
Pelchrzim Rv; Weigmann HJ; Schaefer H; Hagemeister T; Linscheid M; Shah VP; Sterry W; Lademann J
J Dtsch Dermatol Ges; 2004 Nov; 2(11):914-9. PubMed ID: 16281609
[TBL] [Abstract][Full Text] [Related]
18. Tachyphylaxis to Topical Therapy with Clobetasol Propionate.
Singh PK
Indian J Dermatol Venereol Leprol; 1989; 55(6):362-363. PubMed ID: 28128116
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bullous pemphigoid with topical clobetasol propionate.
Westerhof W
J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
[TBL] [Abstract][Full Text] [Related]
20. Effect of Topical Steroids on Skin Prick Test: A Randomized Controlled Trial.
Ebbesen AR; Riis LA; Gradman J
Dermatol Ther (Heidelb); 2018 Jun; 8(2):285-290. PubMed ID: 29728933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
